AstraZeneca Plc said the company’s Covid-19 vaccine trial in the United States is still on hold.
AstraZeneca Plc paused global trials, including large late-stage studies, of the company’s experimental coronavirus vaccine because of an unexplained illness in a study participant.
The U.S. Centers for Disease Control and Prevention (CDC) asked state public health officials to prepare to distribute a potential coronavirus vaccine to high-risk groups as soon as late October, documents published by the agency showed.
Several large U.S. states are not heeding new federal health officials’ calls to reduce Covid-19 testing of some exposed to the virus, joining a broad rebuke of the Trump administration by public health leaders.
The U.S. Food and Drug Administration placed a hold on the Emergency Use Authorization for convalescent plasma as a potential treatment for Covid-19 over what was described as a lack of robust data supporting its use.
The World Health Organization is reviewing a report that suggested the WHO’s advice on the novel coronavirus needs updating, after some scientists told the New York Times there was evidence the virus could be spread by tiny particles in the air.
Hundreds of scientists say there is evidence that novel coronavirus in smaller particles in the air can infect people and are calling for the World Health Organization to revise recommendations, the New York Times reported.
Control Charts Best Method to Identify Real Improvements SEATTLE, April 8, 2020 /PRNewswire/ — MDmetrix, a clinical performance management platform, today announced it has developed new control charts that project daily deaths from COVID-19 nationally and by state. The new charts show whether states are successfully flattening the “daily deaths” curve, using data on […]
Prescription drug prices dropped 1 percent in 2018 – the first time such a drop has occurred in the United States in 45 years – driven primarily by a greater reliance on generic drugs and much slower increases in branded drugs, according to a government study.